Featured articles from the journal CHEST®, June 2023
Glenview, Ill. | June 15, 2023
Published monthly, the journal CHEST(opens in new tab/window)® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The June issue(opens in new tab/window) of the CHEST journal contains 49 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia resources(opens in new tab/window), including visual abstracts, to expand the reach of its most interesting, timely and relevant research.
Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP, says, “When reading through the June issue of the flagship journal, I recommend also looking at the Articles in Press in the new open access publications, CHEST(opens in new tab/window) and CHEST(opens in new tab/window). With full issues publishing in the coming months, they currently feature original research including, ‘Community-Acquired Pneumonia Incidence in Adults 18 Years of Age and Older in Goto City, Japan(opens in new tab/window)’ and ‘ICU Mortality Across Prepandemic and Pandemic Cohorts in a Resource-Limited Setting(opens in new tab/window).’”
Also included in the current issue of the journal CHEST:
Asthma Original research, “Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5(opens in new tab/window),” suggests that sputum markers can be used as surrogate markers of remission one year after therapy. View the visual abstract for this research(opens in new tab/window).
Chest Infections Looking at 1,909 individuals over age 65 who survived hospitalization for community-acquired pneumonia, “Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Older Adult Patients Surviving to Discharge(opens in new tab/window)” suggests that compliance with clinical practice guidelines reduces risk of cardiovascular death at one year post-community-acquired pneumonia.View the visual abstract for this research.(opens in new tab/window)
A population-based cohort study, “New and Persistent Sedative Prescriptions Among Older Adults Following a Critical Illness(opens in new tab/window),” demonstrates that one in 15 sedation-naive older adult ICU survivors filled new sedative prescriptions within a week of discharge, and more than half had refills. View the visual abstract for this research.(opens in new tab/window)
A longitudinal study of 4,432 individuals, “Changing Smoking Behavior and Epigenetics(opens in new tab/window)” finds that methylation in the aryl hydrocarbon receptor repressor gene recovered to a higher degree in individuals who quit smoking compared with individuals who continued smoking or who never smoked.
Notes for editors
To view the entire June issue of CHEST journal (volume 163, issue 6), published by Elsevier(opens in new tab/window), visit journal.chestnet.org(opens in new tab/window) and follow @journal_CHEST(opens in new tab/window) on Twitter for the latest journal news.
Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, Senior Specialist, Communications and Public Relations, American College of Chest Physicians (CHEST), at [email protected](opens in new tab/window).
About the journal CHEST®
The journal CHEST(opens in new tab/window), the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org(opens in new tab/window).
About the American College of Chest Physicians
The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.(opens in new tab/window)
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.
Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet(opens in new tab/window) and Cell(opens in new tab/window); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(opens in new tab/window) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.
Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers.